References
- Alsen C., Harris J. B, Tesseraux I. Brit. J. Pharmacol. (1981); 74: 61–71
- Béress L., Béress R, Wunderer G. Toxicon (1975); 13: 359–367
- Bowman W. C, Raper C. Brit. J. Pharmacol. (1965); 24: 98–109
- Chang C. C, Tseng K. H. Brit. J. Pharmacol. (1978); 63: 551–559
- Chang C. C., Hong S. J, Su M. J. Brit. J. Pharmacol. (1983); 79: 673–680
- Erxleben C, Rathmaver W. Toxicon (1984); 22: 387–399
- Falk G, Landa J. F. Amer. J. Physiol. (1960); 198: 289–299
- Frank G. B. Biochem. Pharmacol. (1980); 29: 2399–2406
- Frank G. B. Can. J. Physiol. Pharmacol. (1984); 62: 374–378
- Kuschinsky G., Lüllmann H, Pracht W. Pflugers Arch. ges. Physiol. (1959); 268: 254–257
- Li C.-L., Shy G. M, Wells J. J. Physiol. (London) (1957); 135: 522–535
- Lüllmann H. Naunyn-Schmiedeberg's Arch. Exp. Pathol. Pharmakol. (1961); 240: 351–360
- Lüllmann H, Muscholl E. Naunyn-Schmiedeberg's Arch. Exp. Pathol. Pharmakol. (1954); 221: 209–214
- Madeira A. C, Suarez-Kurtz G. J. Physiol. (London) (1983); 338: 339–353
- Molgo J., Lemeignan M, Tazieff-Depierre F. IRCS Med. Science (1982); 10: 730
- Pappone P. A. J. Physiol. (London) (1980); 306: 377–410
- Purves D, Sakmann B. J. Physiol. (London) (1974, a); 239: 125–153
- Purves D, Sakmann B. J. Physiol. (London) (1974, b); 237: 157–182
- Rathmayer W, Béress L. J. Comp. Physiol. (1976); 109: 373–382
- Ravens U, Schöllhorn E. Naunyn-Schiedeberg's Arch. Pharmacol. (1981); 316: R51
- Ravens U, Schöllhorn E. Toxicon (1983); 21: 131–142
- Romey G., Abita J. P., Schweitz H., Wunderer G, Lazdunski M. Proc. Nat. Acad. Sci. USA (1976); 73: 4055–4059
- Smith J. W, Thesleff S. J. Physiol. (London) (1976); 257: 171–186
- Tesseraux I, Alsen C. Toxicon (1979); 17: 188
- Thesleff S. The Effect of Use and Disuse on Neuromuscular Junctions, P. Hnik. Elsevier Publishing Co., Amsterdam (1963); 41–51
- Thesleff S, Ward M. R. J. Physiol. (London) (1975); 244: 313–323